Arbor Capital Management Lowers stake in Vascular Solutions (VASC)

Vascular Solutions (VASC) : Arbor Capital Management reduced its stake in Vascular Solutions by 28.87% during the most recent quarter end. The investment management company now holds a total of 84,477 shares of Vascular Solutions which is valued at $3,985,625 after selling 34,279 shares in Vascular Solutions , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Vascular Solutions makes up approximately 1.99% of Arbor Capital Management’s portfolio.

Other Hedge Funds, Including , Mairs Power Inc boosted its stake in VASC in the latest quarter, The investment management firm added 100 additional shares and now holds a total of 75,653 shares of Vascular Solutions which is valued at $3,569,309. Vascular Solutions makes up approx 0.05% of Mairs Power Inc’s portfolio. Mycio Wealth Partners sold out all of its stake in VASC during the most recent quarter. The investment firm sold 29 shares of VASC which is valued $1,368.Blackrock Investment Management boosted its stake in VASC in the latest quarter, The investment management firm added 4,584 additional shares and now holds a total of 74,611 shares of Vascular Solutions which is valued at $3,520,147.Conestoga Capital Advisors reduced its stake in VASC by selling 185,972 shares or 14.92% in the most recent quarter. The Hedge Fund company now holds 1,060,111 shares of VASC which is valued at $45,404,554. Vascular Solutions makes up approx 3.30% of Conestoga Capital Advisors’s portfolio.

Vascular Solutions opened for trading at $48.07 and hit $48.74 on the upside on Thursday, eventually ending the session at $48.46, with a gain of 0.60% or 0.29 points. The heightened volatility saw the trading volume jump to 56,876 shares. Company has a market cap of $848 M.

On the company’s financial health, Vascular Solutions reported $0.33 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $0.30. The company had revenue of $41.19 million for the quarter, compared to analysts expectations of $41.07 million. The company’s revenue was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.29 EPS.

Many Wall Street Analysts have commented on Vascular Solutions. Vascular Solutions was Downgraded by Sidoti to ” Neutral” on Jul 12, 2016.

Vascular Solutions Inc. is a medical device company which creates minimally invasive medical devices and then delivers these products and services to physicians through its direct domestic sales force and its international distribution network. It offers products and services in three categories: Catheter products which consist of catheters used in minimally invasive medical procedures for the treatment of vascular conditions such as GuideLiner and Pronto extraction catheters and includes micro-introducer kits for gaining percutaneous access to the vasculature; Hemostat products which consist of the D-Stat Dry hemostat to control surface bleeding D-Stat Flowable for preventing bleeding in subcutaneous pockets Accumed wrist positioning splints and Vasc Band inflatable compression bands and Vein products which consist of the Vari-Lase endovenous laser for the treatment of varicose veins and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Vascular Solutions - Is it time to Sell?

Top Brokerage Firms are advising their investors on Vascular Solutions. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.